Sargent Investment Group, LLC
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1766157
BETHESDA, MD
Position in TEVA
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,551,100
+$625,561 QoQ
Shares Held
134,330
+3.1% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#200
of 671 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Derivatives in TEVA
reported options exposure · as of Sep 30, 2022CallValue
$11,000
CallShares
200,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Sargent Investment Group, LLC holds $4,873,320 across 2 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (93.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
134,330 | $4,551,100 | |
| 2 | ZTS |
Zoetis Inc.
|
4,484 | $322,220 |
All Filings in TEVA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,551,100 | 134,330 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $3,925,539 | 130,330 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $4,015,790 | 128,670 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,598,124 | 128,620 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,250,784 | 134,295 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,510,794 | 98,295 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $2,188,461 | 99,295 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $1,969,586 | 109,300 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $1,991,925 | 122,580 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,757,823 | 124,580 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,326,924 | 127,100 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,296,420 | 127,100 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,093,167 | 145,175 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $2,784,873 | 314,675 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $2,815,116 | 308,675 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $11,000 | 200,000 | Call | Sole | 2022-10-27 | |
| 2022-09-30 | $2,313,467 | 286,675 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $1,617,514 | 215,095 | Shares | Sole | 2022-07-26 | |
| 2022-06-30 | $42,000 | 100,000 | Call | Sole | 2022-07-26 | |
| 2022-03-31 | $115,000 | 100,000 | Call | Sole | 2022-05-06 | |
| 2021-12-31 | $420,925 | 52,550 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $59,000 | 200,000 | Call | Sole | 2021-11-12 | |
| 2021-09-30 | $24,837 | 2,550 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $51,000 | 100,000 | Call | Sole | 2021-08-05 | |
| 2021-06-30 | $25,245 | 2,550 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $55,000 | 150,000 | Call | Sole | 2021-05-04 | |
| No filing history on record for this holder in this stock. | ||||||